MIRXES LAB PTE. LTD.
Last Updated: 13 Apr 2026
MiRXES is a Singapore-headquartered biotechnology company focused on developing and commercializing innovative diagnostic solutions for early, actionable, and personalized disease detection. With a strong presence in Asia and global ambitions, we have established research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. Our flagship product, GASTROClear, is a molecular blood test for early detection of gastric cancer, with plans to expand our cancer portfolio to include tests for lung, thyroid, colorectal, and breast cancer. Additionally, we are developing a precision oncology portfolio to provide clinical insights for the complete patient journey. Leveraging our versatile platform technology and capabilities, we aim to address unmet clinical needs in various disease areas, including cardiovascular, metabolic, and infectious diseases. In response to COVID-19, we have leveraged our capabilities to mass produce and distribute the Fortitude COVID-19 RT-PCR test, which has been deployed in multiple hospitals and clinical labs worldwide.
Country of registration | Singapore |
Registration number | 201821575C |
Local SIC | |
Incorporation date | 26 Jun 2018 |
Company age | 7 years 11 months |
Official entity type | Private Limited Company |
No. of officers | 12 |
Contact
Address:
11 BIOPOLIS WAY, #08-03, HELIOS, Singapore 138667
Phone number:
Access Key Decision Makers
This is the legal entity page of MIRXES LAB PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (2)
- MIRXESView MoreSingaporeMiRXES is a Singapore-headquartered biotechnology company focused on developing and commercializing innovative diagnostic solutions for early, actionable, and personalized disease detection. With a strong presence in Asia and global ambitions, we have established research, development, manufacturing, and clinical diagnostic operations in Singapore, USA, Japan, and China. Our flagship product, GASTROClear, is a molecular blood test for early detection of gastric cancer, with plans to expand our cancer portfolio to include tests for lung, thyroid, colorectal, and breast cancer. Additionally, we are developing a precision oncology portfolio to provide clinical insights for the complete patient journey. Leveraging our versatile platform technology and capabilities, we aim to address unmet clinical needs in various disease areas, including cardiovascular, metabolic, and infectious diseases. In response to COVID-19, we have leveraged our capabilities to mass produce and distribute the Fortitude COVID-19 RT-PCR test, which has been deployed in multiple hospitals and clinical labs worldwide.
- View MoreMiRXES microRNA Centre of Excellence is a division of MiRXES, a biotech company focused on saving lives through early, actionable, and personalized diagnoses. We have commercialized an industry-leading qPCR-based technology for microRNA detection, which has been adopted by top academic and industry partners globally. Our patented RT-qPCR technology platform enables sensitive, specific, and robust detection of microRNAs and other non-coding RNAs in biofluids and tissue samples.
This is the legal entity page of MIRXES LAB PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | KPMG LLP |
Revenue | 11m - 25m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 7,056,279 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of MIRXES LAB PTE. LTD.?
- Where is MIRXES LAB PTE. LTD.'s headquarter?
- What is MIRXES LAB PTE. LTD.'s contact number?
- What MIRXES LAB PTE. LTD.'s spending power?
- Does MIRXES LAB PTE. LTD. have a presence in the domain it operates in?